Biocryst Pharmaceuticals (BCRX) Return on Assets (2011 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Return on Assets came in at 0.01% in Q1 2026, down 1.0% YoY from 0.01% in Q1 2025, and down 270.27% on a QoQ basis from 0.01% in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Return on Assets (2011 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 16 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.
- Quarterly Return on Assets fell 1.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (down 1.0% YoY) and the FY2025 annual result came in at 0.01%, up 1.0% from the prior year.
- Return on Assets retreated to 0.01% in Q1 2026, from 0.01% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.01% in Q4 2025 to a low of 0.01% in Q1 2026.
- A 5-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2025 — Return on Assets gained 1 bps — and 2026, when it slipped 1 bps.
- Tracing BCRX's Return on Assets over 5 years: stood at 0.0% in 2022, then rose by 2 bps to 0.0% in 2023, then surged by 58 bps to 0.0% in 2024, then soared by 403 bps to 0.01% in 2025, then sank by 270 bps to 0.01% in 2026.
- The last three Return on Assets figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 0.00% |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 0.00% |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | 0.01% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | -0.01% |